Clene(us:CLNN)

2.85

-2.06%

Updated on 2025-05-06

Open:2.92
Close:2.85
High:2.93
Low:2.80
Prev Close:2.91
Volume:20672.00
Turnover:58868.00
Turnover Ratio:0.23%
Shares:8.98M
MarketCap:25.60M

About Clene

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.

Company Name: Clene
Address: 6550 South Millrock Drive,Suite G50
Employees: 85
Fiscar Year: 12-31
IPO Date: 2018-08-27
CIK: 1822791

View all SEC Filings

About

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.
Address:6550 South Millrock Drive,Suite G50

Market Movers